deferiprone
Showing 1 - 24 of 24
Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)
No longer available
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone
- (no location specified)
Nov 9, 2022
Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Deferiprone
- Placebo Oral Tablet
-
Angers, France
- +14 more
Nov 4, 2022
Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
Acute Kidney Injury Trial (deferiprone, Placebo)
Withdrawn
- Acute Kidney Injury
- deferiprone
- Placebo
- (no location specified)
Aug 20, 2020
Parkinson Disease Trial in Worldwide (Deferiprone, Placebo)
Active, not recruiting
- Parkinson Disease
- Deferiprone
- Placebo
-
Innsbruck, Austria
- +24 more
Mar 9, 2021
Parkinson's Disease, Amyotrophic Lateral Sclerosis, Oxidative Stress Trial in Lille (deferiprone, )
Completed
- Parkinson's Disease
- +3 more
- deferiprone
- placebo
-
Lille, FranceHôpital Roger Salengro, CHRU de Lille
Mar 25, 2020
Parkinson's Disease Trial in Worldwide (Deferiprone, Placebo)
Completed
- Parkinson's Disease
- Deferiprone
- Placebo
-
Toronto, Ontario, Canada
- +19 more
Nov 14, 2019
Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer
Completed
- Myelodysplastic Syndrome With Low-grade Lesions
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- Deferiprone
-
Tel Hashomer, IsraelChim Sheba Medical Center
Oct 30, 2018
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)
Unknown status
- Iron Overload
- +2 more
- Deferiprone
-
Oakland, California
- +12 more
Jan 10, 2019
Mild Cognitive Impairment Trial in San Antonio (Deferiprone, Placebo phase)
Withdrawn
- Mild Cognitive Impairment
- Deferiprone
- Placebo phase
-
San Antonio, TexasUniversity of Texas Health Science Center
Feb 5, 2018
ALS (Amyotrophic Lateral Sclerosis), Iron Overload Trial in Lille (Deferiprone)
Completed
- ALS (Amyotrophic Lateral Sclerosis)
- Iron Overload
- Deferiprone
-
Lille, FranceHôpital Roger Salengro, CHRU de Lille
Mar 8, 2017
Diabetes, Iron Metabolism Disorders, Gastroduodenal Ulcer Trial in Jerusalem (Deferiprone, Acetylcysteine, Sitagliptin and
Unknown status
- Diabetes Mellitus
- +5 more
- Deferiprone
- +2 more
-
Jerusalem, IsraelHadassah medical center
Aug 24, 2016
Healthy Volunteers Trial in Mont-Royal (Deferiprone, Placebo)
Completed
- Healthy Volunteers
- Deferiprone
- Placebo
-
Mont-Royal, Quebec, CanadaAlgorithme Pharma Inc.
Dec 4, 2014
Prolonged QTc Interval Trial in Tempe (Deferiprone, deferiprone matching tablets, moxifloxacin)
Completed
- Prolonged QTc Interval
- Deferiprone
- +3 more
-
Tempe, ArizonaCelerion
Nov 7, 2014
Beta Thalassemia Major Trial in Cairo (Deferiprone)
Unknown status
- Beta Thalassemia Major
- Deferiprone
-
Cairo, EgyptPediatric Hematology clinic, Ain Shams University
Jan 13, 2015
HIV Infection Trial in Bloemfontein, (Deferiprone)
Completed
- HIV Infection
- Deferiprone
-
Bloemfontein,, South AfricaPAREXEL International
Jul 14, 2014
Parkinson's Disease Trial in Lille (deferiprone, )
Completed
- Parkinson's Disease
- deferiprone
- placebo
-
Lille, FranceService de Neurologie, Clinique Neurologique, EA 2683, IFR 114
Aug 31, 2012
Iron Overload Trial in Philadelphia (deferiprone)
Approved for marketing
- Iron Overload
- deferiprone
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Feb 8, 2012
Friedreich's Ataxia Trial in Worldwide (, deferiprone)
Completed
- Friedreich's Ataxia
- placebo
- deferiprone
-
Victoria, Australia
- +5 more
May 31, 2010
Beta-Thalassemia Trial in Cagliari (deferiprone)
Unknown status
- Beta-Thalassemia
- deferiprone
-
Cagliari, Sardinia, ItalyOspedale Microcitemico, Via Jenner
Jun 23, 2005